Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05066503

Nutritional Therapy for Delirium in Elderly Hospitalized Subjects

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older adults (60 years and older) who are hospitalized for certain infections. In this study, up to 60 people will be enrolled.20 will be asked to drink this blend twice a day for up to 4 days, and 20 will receive standard treatment in the hospital for the same time period. The other 20 subjects will be non-delirious control subjects who do not consume any study products.

Detailed description

This will be an interventional pilot study to determine the effectiveness of a specific amino acid supplement developed by the investigators versus standard treatment in mitigating delirium in geriatric patients hospitalized at UAMS for certain infections. Up to 40 delirious and 20 non-delirious subjects (Aged 60 years and older) of any gender or ethnicity will be enrolled (60 subjects maximum). Twenty patients with delirium will be asked to drink this blend twice a day for up to 4 days, and 20 patients with delirium will receive standard treatment in the hospital for the same time period. The other 20 subjects will be non-delirious control subjects who do not consume any study products. All subjects will undergo 2-5 blood draws and 3-7 cognitive assessments while they are admitted to the hospital, depending on study group assignment and discharge date.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT260279 active study productThe active study product (20g per serving) contains 13.6g of amino acids and natural flavors, citric acid, malic acid, and stevia for flavoring.

Timeline

Start date
2020-11-16
Primary completion
2026-08-01
Completion
2027-01-01
First posted
2021-10-04
Last updated
2026-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05066503. Inclusion in this directory is not an endorsement.